期刊文献+

儿童造血干细胞移植后EB病毒感染48例研究分析

Analysis of 48 cases of Epstein-Barr virus infection in children after hematopoietic stem cell transplantation
原文传递
导出
摘要 目的探讨儿童造血干细胞移植术后EB病毒感染的发生率和相关危险因素,为儿童造血干细胞移植术后的防治提供依据。方法回顾性分析2014年1月—2020年12月于我院儿科接受造血干细胞移植术治疗的48例恶性和非恶性血液疾病患儿,均接受清髓预处理方案和减低强度的预处理方案。结果(1)移植前采用定量PCR检测,EB病毒感染阳性率为12.50%(6/48);移植后3个月内采用定量PCR检测,EB病毒感染阳性率为41.67%(20/48),导致淋巴细胞增殖疾病1例(2.08%)。(2)移植前EB病毒阳性患儿,在移植后EB病毒感染阳性率为77.08%(37/48);而移植前未感染EB病毒的阴性患儿,在移植后EB病毒感染阳性率为50.00%(24/48),虽然感染率低于前者,但二者差异无显著性(P=0.058)。结论儿童在进行造血干细胞移植后监测EB病毒PCR的指南尚未完善,常规病毒PCR监测结果可提高医疗保健利用率和医源性失血量,并能够有效预防儿童在进行造血干细胞移植后EB病毒感染。 Objective To investigate the incidence and related risk factors of Epstein-Barr virus(EBV)infection after pediatric hematopoietic stem cell transplantation,and to provide evidence for the prevention and treatment of pediatric hematopoietic stem cell transplantation.Methods A retrospective study of 48 pediatric patients undergoing hematopoietic stem cell transplantation for malignant and non-malignant disease at our hospital from January 2014 and December 2020.All of them received pulp removal preconditioning and reduced-intensity preconditioning.Results(1)The positive rate of EBV infection was 12.50%(6/48)by quantitative PCR before transplantation.The positive rate of EBV infection was41.67%(20/48).Within 3 months after transplantation,there was 1 case of lymphocyte proliferative diseases(2.08%).(2)The positive rate of EB infection rate was 77.08%(37/48).The positive rate of EBV infection in the negative children who were not infected before transplantation was50.00%(24/48)after transplantation,although the infection rate was lower than that of the former,there was no significant difference between them(P=0.058).Conclusion The guidelines for monitoring EB virus PCR in children after hematopoietic stem cell transplantation are not yet perfected,and routine viral PCR monitoring results can improve healthcare utilization and iatrogenic blood loss,and effectively prevent EBV infection in children after hematopoietic stem cell transplantation.
作者 刘微 熊暮珺 LIU Wei;XIONG Mu-jun(The First People's Hospital of Chenzhou City,Chenzhou,Hunan,423000,China)
出处 《中国冶金工业医学杂志》 2023年第1期7-8,共2页 Chinese Medical Journal of Metallurgical industry
基金 湘南学院2019年度校级科研项目(2019XJ73)。
关键词 儿童 造血干细胞移植 EB病毒 感染 分析 Children Hematopoietic stem cell transplantation Epstein-Barr virus Infection Analysis
  • 相关文献

参考文献5

二级参考文献90

  • 1谢正德,申昆玲.重视儿童非肿瘤性EB病毒感染疾病的研究[J].首都医科大学学报,2010,31(2):213-216. 被引量:43
  • 2何燕,顾英霞,胡静.更昔洛韦、α-干扰素及利巴韦林治疗小儿传染性单核细胞增多症的研究[J].现代中西医结合杂志,2005,14(17):2242-2243. 被引量:8
  • 3段红梅,申昆玲.慢性活动性EB病毒感染的诊断标准和治疗[J].实用儿科临床杂志,2006,21(10):638-640. 被引量:25
  • 4刘会兰,孙自敏,耿良权,吴振添,汤宝林,王祖贻.造血干细胞移植后EB病毒相关性淋巴增殖性疾病一例分析[J].中华器官移植杂志,2006,27(10):631-633. 被引量:2
  • 5诸福棠.实用儿科学[M].第7版.北京:人民卫生出版社,2002:847-852.
  • 6Fafi-Kremer S,Morand P,Brion JP,et al.Long-term shedding of infectious epstein-barr virus after infectious monomucleosis[J].J Infect Dis,2010,191(6):985.
  • 7Sokal EM,Hoppenbrouwers K,Vandermeulen C,et al.Recombinant gp350 Vaccine for Infectious Mononucleosis:A Phase 2,Randomized,Double-Blind,Placebo-Controlled Trial to Evaluate the Safety,Immunogenicity,and Efficacy of an Epstein-Barr Virus Vaccine in Healthy Young Adults[J].Journal of Infectious Diseases,2007,196(12):1749.
  • 8Zimmerer J M,Lesinski G B,Radmacher M D,et al.STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha[J].Cancer Immunology,2007,56(11):1845.
  • 9Samira F K,Patrice M,Jean-Paul B,et al.Long-Term Shedding of Infectious Epstein-Barr Virus after Infectious Mononucleosis[J].Journal of Infectious Diseases,2006,191(6):985.
  • 10Joseph T Dipiro,Rob ert L Talbert,Gary C Yee,et al.Pharmacotherapy[M].4th Ed.Mc G raw-Hill,2011:239-246.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部